Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-01-06
1999-09-14
Moezie, F. T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514 12, 514 23, 514547, A01M 3718
Patent
active
059522950
ABSTRACT:
An enteral, nutritional composition for the treatment or prophylaxis of inflammatory conditions of the gastro-intestinal tract; for example Crohn's disease. The composition contains: (i) casein rich in TGF-.beta.2; (ii) a lipid source which provides about 35% to about 50% of energy; and (iii) a carbohydrate source.
REFERENCES:
patent: 5461033 (1995-10-01), Donnet et al.
patent: 5661123 (1997-08-01), Stalker et al.
Beattie et al., "Polymeric Nutrition as the Primary Therapy in Children with Small Bowel Crohn's Disease", Alimentary Pharmacology & Therapeutics, vol. 8, 1994, pp. 609-615.
Sanderson et al., "Remission Induced by an Elemental Diet in Small Bowel Crohn's Disease", Archives of Disease in Childhood, vol. 61, 1987, pp. 123-127.
Giaffer et al., "Controlled Trial of Polymeric Versus Elemental Diet in Treatment of Active Crohn's Disease", The Lancet, vol. 335, Apr. 7, 1990, pp. 816-819.
Derwent Abstract AN 97-231148-JP 950254630.
Arnaud-Battandier Franck
Grasset Etienne Alfred
Jaussan Veronique
Moezie F. T.
Nestec S.A.
LandOfFree
Composition and method for treatment of inflammatory conditions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and method for treatment of inflammatory conditions , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method for treatment of inflammatory conditions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1509710